FELDAN BIO INC has a total of 23 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2016. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are SHANGHAI YIHAO BIOTECHNOLOGY CO LTD, SHANGHAI UNICAR THERAPY BIO MEDICINE TECH CO LTD and SHANGHAI HENGRUN DASHENG BIOLOGICAL TECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Canada | 3 | |
#4 | Australia | 2 | |
#5 | China | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | Israel | 2 | |
#8 | Republic of Korea | 2 | |
#9 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds | |
#5 | Measuring microorganism processes | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Guay David | 23 |
#2 | Del'Guidice Thomas | 21 |
#3 | Lepetit-Stoffaes Jean-Pascal | 20 |
#4 | Barbeau Xavier | 2 |
#5 | Lepetit Stoffaes Jean Pascal | 2 |
#6 | Messier Nancy | 2 |
#7 | Del’Guidice Thomas | 2 |
#8 | Le-Petit-Stoffaes Jean-Pascal | 1 |
#9 | Hallée Stéphanie | 1 |
Publication | Filing date | Title |
---|---|---|
CA3040645A1 | Peptide-based non-proteinaceous cargo delivery | |
US2020270307A1 | Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to same | |
EP3526235A1 | Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to same | |
US2018100158A1 | Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to same | |
WO2017175072A1 | Peptide shuttle based gene disruption | |
EP3280739A1 | Polypeptide-based shuttle agents for improving the transduction efficiency of polypeptide cargos to the cytosol of target eukaryotic cells, uses thereof, methods and kits relating to same |